Unfortunately referral of the patients to the therapeutic facilities is usually late in the course of the disease, which severely limits the therapeutic efficacy (3, (5) (6) (7) (8) .
Liver biopsy, Ultrasonography, cholescintigraphy, Endoscopic Retrograde
Cholangio-Pancreatography (ERCP), and duodenal aspiration are the common diagnostic approaches for neonatal cholestasis (9) .
Hepatobiliary scintigraphy is an integral part in the diagnostic work-up of the neonatal cholestasis syndrome. Although the sensitivity of this kind of imaging is very high for detection of biliary atresia (83-100%), less than optimal specificity (75%-80% in most of the series) is its major disadvantage (9) (10) (11) (12) (13) (14) . Entrance of the radiotracer into the bowel excludes biliary atresia in cholescintigraphy, however poor hepatic function impedes
proper biliary excretion and differentiation between neonatal hepatitis and biliary atresia become impossible in some cases (14,15).
It is shown that Phenobarbital, Ursodeoxycholic acid or Betamethasone administration can increase the specificity of hepatobiliary scintigraphy (14- Tc-BrIDA to differentiate biliary atresia from other causes of neonatal jaundice. All patients received Phenobarbital before the study (5 mg/kg in divided doses for 5 days).
Materials and Methods
Parents signed an informed, written consent to participate in the study which was approved by the local ethical committee.
Results:
20 infants (11 male, 9 female) with a mean age of 2.41 months (range, 0. Tc-MIBI scan (Fig. 1) .
Discussion:
Many radiological and laboratory test can aid in the correct diagnosis of biliary atresia. Ultrasonography is an easily accessible, affordable, and Hepatobiliary scintigraphy is an integral part in the diagnostic work-up of the neonatal cholestasis syndrome and has been used for couple of years.
However hepatobiliary scintigraphy has a suboptimal specificity for detection of biliary atresia, which limits its usefulness (9-14). Our study also confirmed this issue (specificity of 50%). Several approaches including premedication with Phenobarbital, betamethasone, and Ursodeoxycholic acid, were reported to increased the specificity of hepatobiliary scintigraphy Tc-MIBI is a substrate for P-glycoprotein, which is normally expressed in biliary canalicular surfaces of hepatocytes and is responsible for the excretion of cationic metabolites from the liver.
This mechanism is completely different from bilirubin excretory mechanism (22,23).
Interestingly, all patients in our study showed small intestinal activity (most likely jejunum) regardless of the etiology of the cholestasis, including 10 patients with biliary atresia. As far as we know, there is only one unpublished study on this subject (26). In this preliminary study, the authors have shown that 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Conclusion:
We concluded that 99m
Tc-MIBI has limited utility in differential diagnosis of the neonatal cholestasis. This curious finding can be due to secretion of this agent into the bowel through P-gp, which is normally expressed in jejunum and colon . 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
